The United Kingdom announced the Vaccine Development and Evaluation Centre
On Aug. 7, 2023, the United Kingdom Health and Security Agency announced the Vaccine Development and Evaluation Centre…
On Aug. 7, 2023, the United Kingdom Health and Security Agency announced the Vaccine Development and Evaluation Centre…
On Aug. 7, 2023, a National Institute of Health supported study found that in 2021, an estimated 2.5…
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthï¾’s…
On Jul. 27, 2023, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
Milestones in Diabetes illustrates major milestones from the first administration of the hormone insulin in 1921 to a…
On Jul. 19, 2023, the National Institute of Health announced that a nationwide research team had created the…
On Jul. 14, 2023, the UK Animal and Plant Health Agency reported that additional asymptomatic human detections of…
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
On Jun. 22, 2023, the Institute for Health Metrics and Evaluation (IHME) reported that more than half a…
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
On May 31, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
On May 25, 2023, the U.S. Food and Drug Administration (FDA) approved the oral antiviral Paxlovid (nirmatrelvir tablets…
On May 24, 2023, the U.S. FDA approved Braeburn pharmaceutical’s Brixadi (buprenorphine) extended-release injection for subcutaneous use (under…
On May 22, 2023, the Institute for Health Metrics and Evaluation (IHMI) reported low back pain remains the…
On May 19, 2023, the U.S. Food and Drug Administration (FDA) approved Krystal Biotech’s Vyjuvek, a herpes-simplex virus…
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
On May 8, 2023, scientists at the National Institutes of Health (NIH) announced that they had identified new…
On May 3, 2023, the U.S. FDA approved GlaxoSmithKline’s Arexvy as the first respiratory syncytial virus (RSV) vaccine…
On May 3, 2023, National Institutes of Health (NIH) scientists announced that they had uncovered new details on…
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
On Apr. 27, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 27, 2023, the Zoonomia Project team announced in in a special issue of Science, that had…
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
On Apr. 20, 2023, Massachusetts Institute of Technology (MIT) researchers announced that have developed machine-learning algorithms that can…